Active

Manipal Health Enterprises Limited

Manipal Health Enterprises Limited IPO Details

Listing Date

-

Bid Price

₹0 - ₹0

Lot Size

0 Shares

Minimum Investment

Issue Size

₹0 Cr

Key Dates to Track

    Here are the important dates you need to know in order to participate in this IPO

tick

Offer Start Date

-

tick

Offer End Date

-

tick

Allotment Date

-

tick

Refund Initiation

-

tick

Demat Transfer

-

tick

Listing Date

-

Manipal Health Enterprises Limited Shareholding Pattern

  Pre-Issue Post-Issue
Promoter Group 0% 0%
Public Group 100% 100%

Manipal Health Enterprises Limited IPO Reservation

QIB Shares Offered 0 (0%)
NII (HNI) Shares Offered 0 (0%)
Retail Shares Offered 0 (0%)
Anchor Investor Shares Offered 0 (0%)
Total Shares Offered 0
Total Shares With Anchor Investor 0

Manipal Health Enterprises Limited IPO Lot Size

Application Lots Shares Amount
Retail (Min) [-] [-] ₹[-]
Retail (Max) [-] [-] ₹[-]
S HNI (Min) [-] [-] ₹[-]
S HNI (Max) [-] [-] ₹[-]
B HNI (MIN) [-] [-] ₹[-]

Manipal Health Enterprises Limited IPO registrar

KFin Techologies Ltd
Phone Number 91 40 67162222/180 03094001
Email Id manipal.ipo@kfintech.com
Website www.kfintech.com

Manipal Health Enterprises Limited IPO Lead Manager

1. Kotak Mahindra Capital Company Limited

2. Axis Capital Limited

3. Goldman Sachs (India) Securities Private Limited

4. Jefferies India Private Limited

5. J.P. Morgan India Private Limited

6. UBS Securities India Private Limited

7. DBS Bank India Limited

Manipal Health Enterprises Limited Financial Information

March 31, 2025 March 31, 2024 March 31, 2023
Net Worth ₹5,847.31 Cr ₹4,015.51 Cr ₹3,242.12 Cr
Reserves and Surplus ₹5,770.25 Cr ₹3,939.88 Cr ₹3,166.49 Cr
Total Borrowing ₹4,766.81 Cr ₹3,943.99 Cr ₹2,149.69 Cr

Strength of Manipal Health Enterprises Limited

  • India's largest multispecialty hospital group by bed capacity with pan-India presence and leadership in our three key regions.
  • We are the only private hospital chain network in India with leadership in three metros (Bengaluru, Kolkata and Pune) with a balanced and diversified presence across metros and non-metros.
  • Widely recognized brand and network of choice for patients, doctors and healthcare professionals.
  • Advanced infrastructure and medical equipment, with a strong focus on clinical excellence.
  • Track record of delivering industry leading growth with strong profitability and efficiency metrics.
  • Repeatable playbook for integrating and scaling transformative acquisitions to improve access to quality healthcare.
  • Experienced leadership team with marquee institutional shareholder support.

Risks Involved

  • A substantial number of its hospitals are located in Karnataka. The company derived 49.55%, 51.55%, 59.98%, and 66.61% of the company's revenue from operations in the six months ended September 30, 2025 and in Fiscals 2025, 2024 and 2023, respectively, from its hospitals in Karnataka. Any loss of business or disruption in the operations of these hospitals or geopolitical or policy changes in Karnataka could have a material adverse effect on the company's business, financial condition, results of operations, cash flows and prospects.
  • The company primarily generate revenue by providing inpatient care at the company's hospitals. Any inability to maintain or improve its admissions and hospital occupancy rates could adversely affect the company's business, financial condition, results of operations, cash flows and prospects.
  • The company deriveds 64.08%, 62.56%, 61.55% and 60.25% of its gross inpatient revenue from cardiac sciences, oncology, neurosciences, gastro sciences, orthopaedics, and renal sciences ("CONGO-R") specialties in the six months ended September 30, 2025 and in Fiscals 2025, 2024 and 2023, respectively, and any negative changes in the demand for these specialties could adversely impact the company's business, results of operations and financial condition.
  • The company is exposed to legal claims and regulatory actions arising from the provision of healthcare services and may be subject to liabilities arising from operational and equipment-related risks, which could materially and adversely affect its reputation, financial position, and results of operations. Further, quarantines and sterilizations could limit the operations of hospitals and result in reputational damage.
  • The company may be subject to claims arising from alleged medical negligence by its doctors and other healthcare professionals, which could materially and adversely affect the company's reputation and business.
  • Acquisitions, strategic investments, partnerships or alliances may be difficult to identify, acquire and integrate, and may adversely affect its business, financial condition, results of operations, cash flows and prospects.
  • Any failures to maintain and enhance its brand and reputation, and any negative publicity and allegations in the media against the company, may adversely affect the level of trust in its services and market recognition, which could have an adverse impact on the company's business, financial condition, results of operations, cash flows and prospects.
  • The company is requireds to obtain, renew and maintain statutory and regulatory permits, licenses and accreditations and comply with prescribed quality standards. Any regulatory changes or violations of such rules and regulations, or failures to obtain or renew approvals, licenses, registrations and permits to operate our business or comply with prescribed quality standards in a timely manner, or at all, may adversely affect its business, financial condition, results of operations, cash flows and prospects.
  • The company may experience delays in construction or commencement of operations at new hospitals that the company builds, and the company may be unsuccessful in developing other facilities in the future, in a timely manner or at all, which may have an adverse effect on its growth, business, financial condition, results of operations, cash flows and prospects.
  • There are outstanding proceedings against the Company, Promoters, Directors, Subsidiaries, Key Managerial Personnel and Senior Management. An adverse outcome in any of these proceedings may adversely affect its business, reputation, brand, financial condition, results of operations, cash flows and prospects.
stock

Invest in IPOs with ease

Sign-in to invest with your demat account, or set up a new demat account for free

Explore Other IPOs

  • Current IPOs
  • Upcoming IPOs
  • Closed IPOs
  • IPO Performance
  • All
  • MainBoard
  • SME
Leapfrog Engineering Services Limited IPO
Bidding Period
23rd Apr 2026 - 4th Apr 2026
Price Range
₹21.0 - 23.0
IPO Size
₹88,51,00,000
Aarvee Engineering Consultants Limited IPO
Bidding Period
To Be Announced
Price Range
₹0.0 - 0.0
IPO Size
₹0
Aastha Spintex Limited IPO
Bidding Period
To Be Announced
Price Range
₹0.0 - 0.0
IPO Size
₹0
Absolute Project India Limited IPO
Bidding Period
To Be Announced
Price Range
₹0.0 - 0.0
IPO Size
₹0
AceVector Limited IPO
Bidding Period
To Be Announced
Price Range
₹0.0 - 0.0
IPO Size
₹0
Adroit Industries India Limited IPO
Bidding Period
To Be Announced
Price Range
₹0.0 - 0.0
IPO Size
₹0
Advanced SysTek Limited IPO
Bidding Period
To Be Announced
Price Range
₹0.0 - 0.0
IPO Size
₹0
Advanta Enterprises Limited IPO
Bidding Period
To Be Announced
Price Range
₹0.0 - 0.0
IPO Size
₹0
Advit Jewels Limited IPO
Bidding Period
To Be Announced
Price Range
₹0.0 - 0.0
IPO Size
₹0
Aggcon Equipments International Limited IPO
Bidding Period
To Be Announced
Price Range
₹0.0 - 0.0
IPO Size
₹0
Agilus Diagnostics Limited IPO
Bidding Period
To Be Announced
Price Range
₹0.0 - 0.0
IPO Size
₹0
Airox Technologies Limited IPO
Bidding Period
To Be Announced
Price Range
₹0.0 - 0.0
IPO Size
₹0
Ajay Poly Limited IPO
Bidding Period
To Be Announced
Price Range
₹0.0 - 0.0
IPO Size
₹0
Alcobrew Distilleries India Limited IPO
Bidding Period
To Be Announced
Price Range
₹0.0 - 0.0
IPO Size
₹0
Allchem Lifescience Limited IPO
Bidding Period
To Be Announced
Price Range
₹0.0 - 0.0
IPO Size
₹0
Allied Engineering Works Limited IPO
Bidding Period
To Be Announced
Price Range
₹0.0 - 0.0
IPO Size
₹0
Alpine Texworld Limited IPO
Bidding Period
To Be Announced
Price Range
₹0.0 - 0.0
IPO Size
₹0
Annu Projects Limited IPO
Bidding Period
To Be Announced
Price Range
₹0.0 - 0.0
IPO Size
₹0
AOne Steels India Limited IPO
Bidding Period
To Be Announced
Price Range
₹0.0 - 0.0
IPO Size
₹0
APPL Containers Limited IPO
Bidding Period
To Be Announced
Price Range
₹0.0 - 0.0
IPO Size
₹0
NO ACTIVE IPO HERE
  • All
  • MainBoard
  • SME
CITIUS TRANSNET INVESTMENT TRUST IPO
Bidding Period
17th Apr 2026 - 4th Apr 2026
Price Range
₹99.0 - 100.0
IPO Size
₹11,05,00,00,000
MEHUL TELECOM LIMITED IPO
Bidding Period
17th Apr 2026 - 4th Apr 2026
Price Range
₹96.0 - 98.0
IPO Size
₹28,00,00,000
OM POWER TRANSMISSION LIMITED IPO
Bidding Period
9th Apr 2026 - 4th Apr 2026
Price Range
₹166.0 - 175.0
IPO Size
₹1,50,00,00,000
SAFETY CONTROLS AND DEVICES LIMITED IPO
Bidding Period
6th Apr 2026 - 4th Apr 2026
Price Range
₹75.0 - 80.0
IPO Size
₹48,00,00,000
EMIAC TECHNOLOGIES LIMITED IPO
Bidding Period
27th Mar 2026 - 4th Apr 2026
Price Range
₹93.0 - 98.0
IPO Size
₹32,00,00,000
VIVID ELECTROMECH LIMITED IPO
Bidding Period
25th Mar 2026 - 3rd Mar 2026
Price Range
₹528.0 - 555.0
IPO Size
₹1,31,00,00,000
HIGHNESS MICROELECTRONICS LIMITED IPO
Bidding Period
24th Mar 2026 - 3rd Mar 2026
Price Range
₹114.0 - 120.0
IPO Size
₹22,00,00,000
AMIR CHAND JAGDISH KUMAR EXPORTS LIMITED IPO
Bidding Period
24th Mar 2026 - 3rd Mar 2026
Price Range
₹201.0 - 212.0
IPO Size
₹4,40,00,00,000
SAI PARENTERAL'S LIMITED IPO
Bidding Period
24th Mar 2026 - 3rd Mar 2026
Price Range
₹372.0 - 392.0
IPO Size
₹4,09,00,00,000
POWERICA LIMITED IPO
Bidding Period
24th Mar 2026 - 3rd Mar 2026
Price Range
₹375.0 - 395.0
IPO Size
₹11,00,00,00,000
TIPCO ENGINEERING INDIA LIMITED IPO
Bidding Period
23rd Mar 2026 - 3rd Mar 2026
Price Range
₹84.0 - 89.0
IPO Size
₹61,00,00,000
SPECIALITY MEDICINES LIMITED IPO
Bidding Period
20th Mar 2026 - 3rd Mar 2026
Price Range
₹117.0 - 124.0
IPO Size
₹29,00,00,000
CENTRAL MINE PLANNING AND DESIGN INSTITUTE LIMITED IPO
Bidding Period
20th Mar 2026 - 3rd Mar 2026
Price Range
₹163.0 - 172.0
IPO Size
₹18,42,00,00,000
NOVUS LOYALTY LIMITED IPO
Bidding Period
17th Mar 2026 - 3rd Mar 2026
Price Range
₹139.0 - 146.0
IPO Size
₹60,00,00,000
GSP CROP SCIENCE LIMITED IPO
Bidding Period
16th Mar 2026 - 3rd Mar 2026
Price Range
₹304.0 - 320.0
IPO Size
₹4,00,00,00,000
INNOVISION LIMITED IPO
Bidding Period
10th Mar 2026 - 3rd Mar 2026
Price Range
₹494.0 - 519.0
IPO Size
₹3,06,00,00,000
RAAJMARG INFRA INVESTMENT TRUST IPO
Bidding Period
11th Mar 2026 - 3rd Mar 2026
Price Range
₹99.0 - 100.0
IPO Size
₹60,00,00,00,000
APSIS AEROCOM LIMITED IPO
Bidding Period
11th Mar 2026 - 3rd Mar 2026
Price Range
₹104.0 - 110.0
IPO Size
₹36,00,00,000
RAJPUTANA STAINLESS LIMITED IPO
Bidding Period
9th Mar 2026 - 3rd Mar 2026
Price Range
₹116.0 - 122.0
IPO Size
₹2,55,00,00,000
SRINIBAS PRADHAN CONSTRUCTIONS LIMITED IPO
Bidding Period
6th Mar 2026 - 3rd Mar 2026
Price Range
₹91.0 - 98.0
IPO Size
₹20,00,00,000
  • All
  • MainBoard
  • SME
GSP CROP SCIENCE LIMITED IPO
Issue Prize
320.00
Listing Day Close
356.10(11.25%)
INNOVISION LIMITED IPO
Issue Prize
519.00
Listing Day Close
372.80(-28.13%)
RAAJMARG INFRA INVESTMENT TRUST IPO
Issue Prize
100.00
Listing Day Close
106.83(7.00%)
APSIS AEROCOM LIMITED IPO
Issue Prize
110.00
Listing Day Close
160.65(46.36%)
RAJPUTANA STAINLESS LIMITED IPO
Issue Prize
122.00
Listing Day Close
112.90(-7.38%)
SRINIBAS PRADHAN CONSTRUCTIONS LIMITED IPO
Issue Prize
98.00
Listing Day Close
104.40(6.12%)
ELFIN AGRO INDIA LIMITED IPO
Issue Prize
47.00
Listing Day Close
47.60(2.13%)
SEDEMAC MECHATRONICS LIMITED IPO
Issue Prize
1352.00
Listing Day Close
1452.10(7.40%)
ACETECH ECOMMERCE LIMITED IPO
Issue Prize
112.00
Listing Day Close
117.60(5.36%)
STRIDERS IMPEX LIMITED IPO
Issue Prize
72.00
Listing Day Close
66.50(-6.94%)
YAAP DIGITAL LIMITED IPO
Issue Prize
145.00
Listing Day Close
133.35(-8.28%)
OMNITECH ENGINEERING LIMITED IPO
Issue Prize
227.00
Listing Day Close
205.15(-9.69%)
PNGS REVA DIAMOND JEWELLERY LIMITED IPO
Issue Prize
386.00
Listing Day Close
413.95(7.25%)
KIAASA RETAIL LIMITED IPO
Issue Prize
127.00
Listing Day Close
116.85(-7.87%)
MOBILISE APP LAB LIMITED IPO
Issue Prize
80.00
Listing Day Close
67.30(-16.25%)
ACCORD TRANSFORMER AND SWITCHGEAR LIMITED IPO
Issue Prize
46.00
Listing Day Close
52.50(15.22%)
CLEAN MAX ENVIRO ENERGY SOLUTIONS LIMITED IPO
Issue Prize
1053.00
Listing Day Close
867.90(-17.57%)
SHREE RAM TWISTEX LIMITED IPO
Issue Prize
104.00
Listing Day Close
73.45(-29.81%)
GAUDIUM IVF AND WOMEN HEALTH LIMITED IPO
Issue Prize
79.00
Listing Day Close
80.48(1.27%)
MANILAM INDUSTRIES INDIA LIMITED IPO
Issue Prize
69.00
Listing Day Close
52.45(-24.64%)

Frequently Asked Questions

What is Manipal Health Enterprises Limited IPO?

Answer Field

Manipal Health Enterprises Limited IPO is a IPO of [-] equity shares of a face value of ₹[-] aggregating up to ₹[-] Crores. The issue is priced at ₹[-] to ₹[-] per share. The minimum order quantity is [-] Shares. The IPO opens on [-], and closes on [-]. KFin Techologies Ltd is the registrar for the IPO. The shares are proposed to be listed on .

When Manipal Health Enterprises Limited IPO will open?

Answer Field

The Manipal Health Enterprises Limited IPO opens on [-] and closes on [-].

What is the lot size of Manipal Health Enterprises Limited?

Answer Field

Manipal Health Enterprises Limited lot size is [-] shares, and the minimum amount required is ₹[-].

How to apply for Manipal Health Enterprises Limited IPO?

Answer Field

You can apply in Manipal Health Enterprises Limited IPO online using either UPI or ASBA as payment method. ASBA IPO application is available in the net banking of your bank account. UPI IPO application is offered by brokers who don't offer banking services. To apply for an IPO:

• Login to Bajaj Broking account App/Website & click on IPO

• Enter the number of lots and price at which you wish to apply.

• Enter your UPI ID and click on submit. With this, your bid will be placed with the exchange.

• You will receive a mandate notification to block funds in your UPI app.

• Approve the mandate request on your UPI and funds will be blocked.

When is Manipal Health Enterprises Limited IPO allotment?

Answer Field

The finalization of Basis of Allotment for Manipal Health Enterprises Limited IPO will be done on [-], and the allotted shares will be credited to your demat account by [-].

When is Manipal Health Enterprises Limited IPO listing date?

Answer Field

The Manipal Health Enterprises Limited listing date is [-].

Who is the registrar of Manipal Health Enterprises Limited IPO?

Answer Field

The registrar of Manipal Health Enterprises Limited IPO is KFin Techologies Ltd

Which company is the book-running lead manager of the IPO?

Answer Field

Kotak Mahindra Capital Company Limited,Axis Capital Limited,Goldman Sachs (India) Securities Private Limited,Jefferies India Private Limited,J.P. Morgan India Private Limited,UBS Securities India Private Limited,DBS Bank India Limited will be the book-running lead manager of this IPO.

What is the fresh issue of Manipal Health Enterprises Limited IPO?

Answer Field

The fresh issue size is ₹[-] Crores equity shares.

What minimum lot size can retail subscribers subscribe to Manipal Health Enterprises Limited?

Answer Field

Retail investors can subscribe to a minimum of one lot, [-] shares and ₹[-] amount.

How can I approve the UPI mandate request for Manipal Health Enterprises Limited IPO?

Answer Field

To apply for Manipal Health Enterprises Limited IPO, you need to log in to your demat account to complete the bidding process. Then, approve the payment mandate on your UPI app.

What is the price range of Manipal Health Enterprises Limited?

Answer Field

The price of each Manipal Health Enterprises Limited share will be ranging in between ₹[-] to ₹[-] per share.

What is the cut-off time for the UPI mandate for Manipal Health Enterprises Limited IPO?

Answer Field

The cut-off time for the UPI mandate confirmation is 5:00 PM, [-].

No results found

banner-icon

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|

Please Enter Mobile Number

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|